| Product Name | NebuSelect™ Recombinant Biotinylated Human CDH17/Cadherin 17, Avi-His-tag |
|---|---|
| Catalog Number | NBL-240726 |
| Alias/Synonyms | |
| Appearance | see COA |
| Molecule Weight | Gln23-Met787 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Target |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-240726-100ug | 100ug | Inquire | Inquire | |
| NBL-240726-1mg | 1mg | Inquire | Inquire | |
| NBL-240726-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human CDH17/Cadherin 17, Avi-His-tag
Catalog#:
NBL-240726
Description:
NebuSelect™ Recombinant Biotinylated Human CDH17/Cadherin 17, Avi-His-tag(Cat#NBL-240726) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Gln23-Met787.
Species:
Target
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 87.88 kDa. Due to glycosylation, the protein migrates to 105-120 kDa based on Bis-Tris PAGE result.
Target Name:
Target Information:
Liver-intestine cadherin (CDH17) has been known to function as a tumor stimulator and diagnostic marker for almost two decades.In vivo studies showed CDH17 knockout resulted in apoptotic PC tumor death through activating caspase-3 activity. Taken together, CDH17 functions as an oncogenic molecule critical to PC growth by regulating tumor apoptosis signaling pathways and CDH17 could be targeted to develop an anti-PC therapeutic approach.
Amino Acid Sequence:
Gln23-Met787
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.